Wikidata

(Q61861624)

English

Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds

scientific article published on 01 November 2000

In more languages

Statements

title
Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11114103
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11114103%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 November 2019
author name string
Carina T�rn
series ordinal
1
0 references
Jan �stman
series ordinal
3
0 references
Bengt Scherst�n
series ordinal
4
0 references
Hans Arnqvist
series ordinal
5
0 references
G�ran Blohm�
series ordinal
6
0 references
Elisabeth Bj�rk
series ordinal
7
0 references
Jan Bolinder
series ordinal
8
0 references
Jan Eriksson
series ordinal
9
0 references
Bengt Littorin
series ordinal
10
0 references
Lennarth Nystr�m
series ordinal
11
0 references
G�ran Sundkvist
series ordinal
12
0 references
�ke Lernmark
series ordinal
13
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61861624&oldid=2125832305"